GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CanSino Biologics Inc (SHSE:688185) » Definitions » Price-to-Free-Cash-Flow

CanSino Biologics (SHSE:688185) Price-to-Free-Cash-Flow : N/A (As of Jun. 09, 2024)


View and export this data going back to 2020. Start your Free Trial

What is CanSino Biologics Price-to-Free-Cash-Flow?

As of today (2024-06-09), CanSino Biologics's share price is ¥47.59. CanSino Biologics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 was ¥-2.58. Hence, CanSino Biologics's Price-to-Free-Cash-Flow Ratio for today is N/A.

The historical rank and industry rank for CanSino Biologics's Price-to-Free-Cash-Flow or its related term are showing as below:

During the past 8 years, CanSino Biologics's highest Price-to-Free-Cash-Flow Ratio was 203.97. The lowest was 39.69. And the median was 151.32.

SHSE:688185's Price-to-Free-Cash-Flow is not ranked *
in the Drug Manufacturers industry.
Industry Median: 22.85
* Ranked among companies with meaningful Price-to-Free-Cash-Flow only.

CanSino Biologics's Free Cash Flow per Share for the three months ended in Mar. 2024 was ¥-0.98. Its Free Cash Flow per Share for the trailing twelve months (TTM) ended in was ¥-2.58.

During the past 12 months, the average Free Cash Flow per Share Growth Rate of CanSino Biologics was -563.00% per year. During the past 3 years, the average Free Cash Flow per Share Growth Rate was -21.20% per year.

During the past 8 years, CanSino Biologics's highest 3-Year average Free Cash Flow per Share Growth Rate was -21.20% per year. The lowest was -104.30% per year. And the median was -33.15% per year.


CanSino Biologics Price-to-Free-Cash-Flow Historical Data

The historical data trend for CanSino Biologics's Price-to-Free-Cash-Flow can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CanSino Biologics Price-to-Free-Cash-Flow Chart

CanSino Biologics Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Free-Cash-Flow
Get a 7-Day Free Trial - - 44.88 - -

CanSino Biologics Quarterly Data
Dec16 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Free-Cash-Flow Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 69.31 173.18 - - -

Competitive Comparison of CanSino Biologics's Price-to-Free-Cash-Flow

For the Drug Manufacturers - Specialty & Generic subindustry, CanSino Biologics's Price-to-Free-Cash-Flow, along with its competitors' market caps and Price-to-Free-Cash-Flow data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


CanSino Biologics's Price-to-Free-Cash-Flow Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CanSino Biologics's Price-to-Free-Cash-Flow distribution charts can be found below:

* The bar in red indicates where CanSino Biologics's Price-to-Free-Cash-Flow falls into.



CanSino Biologics Price-to-Free-Cash-Flow Calculation

CanSino Biologics's Price-to-Free-Cash-Flow ratio for today is calculated as

Price-to-Free-Cash-Flow Ratio=Share Price/ Free Cash Flow per Share (TTM)
=47.59/-2.583
=N/A

CanSino Biologics's Share Price of today is ¥47.59.
CanSino Biologics's Free Cash Flow per Share for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ¥-2.58.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

Price-to-Free-Cash-Flow Ratio=Market Cap/Free Cash Flow

CanSino Biologics  (SHSE:688185) Price-to-Free-Cash-Flow Explanation

Free Cash Flow is considered more important than earnings by value investors. The reason is because, in principle, only the net cash that can be taken from the business belongs to shareholders. This Free Cash Flow can be used to grow the business, reduce debt or return to shareholders in dividends or share buybacks.

In a DCF Calculation Free Cash Flow is used to determine the intrinsic value of companies.


Be Aware

In real business, Free Cash Flow can be affected by the change in accounts receivable, accounts payable, management's decision on expansion, etc. Therefore, investors should look at the Free Cash Flow over the longer term. Long-term average of Free Cash Flow is a more reliable indicator for real free cash flow.


CanSino Biologics Price-to-Free-Cash-Flow Related Terms

Thank you for viewing the detailed overview of CanSino Biologics's Price-to-Free-Cash-Flow provided by GuruFocus.com. Please click on the following links to see related term pages.


CanSino Biologics (SHSE:688185) Business Description

Traded in Other Exchanges
Address
185 South Avenue, 401-420, 4th Floor, Biomedical Park, TEDA West District, Tianjin, CHN
CanSino Biologics Inc is a China-based company engaged in the research and development, manufacturing and commercialization of vaccine products for human use. These include products such as pneumococcal polysaccharide and conjugate vaccines as well as a DTcP-based combo and other items. At the same time, the group is also dedicated to the development of new vaccine-like recombinant adenovirus vector-based tuberculosis vaccines and a recombinant protein-based pneumococcal vaccine. Geographically, the activities are carried out through China.

CanSino Biologics (SHSE:688185) Headlines

No Headlines